Year-over-year earnings per share growth for the last twelve months: Exact Sciences (EXAS)

Corporate emblem and logo of Cologuard (EXAS)

Exact Sciences relies on external partners for logistics and IT data transmission. The quarterly EPS growth vector demonstrates profit dynamics, where the value 91.00 represents the current figure. The robotization of pipelines eliminates human error when processing thousands of cancer tests. The company's strategy focuses on scaling early detection systems for various tumors and implementing new diagnostic platforms.

Exact Sciences Corp (EXAS) - Earnings per share growth in annualized terms for the last twelve months from 07/04/2022 to 04/04/2026
Flagship merchandise of Exact Sciences Inc.

Investors must identify resilient assets through rigorous fundamental filters. This metric measures net income per share dynamics compared to the same period last year, filtering out market noise. For Exact Sciences (EXAS), this confirms stable demand for vital cancer screening. A seasonal downturn at year-end makes quarterly earnings per share growth a key indicator of true business efficiency. Analyzing this chart helps avoid buying at the peak of emotional expectations.

Competitor analysis for Exact Sciences

A: Quarterly EPS earnings growth|DGX - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Illumina Corp|Revvity Corp (RVTY) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth BIO|NNNN - Earnings per share growth in annualized terms for the last twelve months|Sotera Health - Year-over-year net earnings per share growth for the last 12 months|QDEL: Year-over-year earnings per share growth for the last 12 months|OPKO Corp - Quarterly EPS earnings growth|CDNA - Quarterly EPS earnings growth|MRVI: Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months fulgentgenetics.com|Year-over-year net earnings per share growth for the last 12 months LAB|CTKB (Cytek Biosciences Inc) - Year-over-year earnings per share growth rate for the last twelve months|Year-over-year net earnings per share growth for the last 12 months OSUR (OraSure Technologies Inc)|XGN (exagen.com) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months MDxHealth SA MDXH|Year-over-year net earnings per share change for the last twelve months luciddx.com (LUCD)|Prenetics Global Ltd - Quarterly EPS earnings growth|Insight Molecular Diagnostics (IMDX) - Year-over-year net earnings per share growth for the last 12 months|TRIB: Quarterly EPS earnings growth|PRPH - Year-over-year net earnings per share change for the last twelve months|AIMD (Ainos, Inc.) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months codiagnostics.com CODX|Year-over-year earnings per share growth for the last twelve months HeartSciences (HSCS)|Biomerica Inc. - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth CDIO (Cardio Diagnostics Holdings)|ONCO - Year-over-year net earnings per share growth for the last 12 months|Virax Biolabs Group - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months bluejaydx.com|Aspira Women's Health Inc. (AWH) - Year-over-year earnings per share growth for the last twelve months|AXDX - Year-over-year net earnings per share change for the last twelve months|CNTG (CENTOGENE) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Enzo ENZ|Year-over-year net earnings per share growth for the last 12 months FRES (Fresh2 Group Limited)|gtglabs.com - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth ME (23andMe)|Quarterly EPS earnings growth Psychemedics Corp. PMD